PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics ; volume:7 ; number:1 ; day:12 ; month:7 ; year:2017 ; pages:1-11 ; date:12.2017
Scientific reports ; 7, Heft 1 (12.7.2017), 1-11, 12.2017
- Creator
-
Bychkov, Andrey
- Contributor
-
Vutrapongwatana, Usanee
Tepmongkol, Supatporn
Keelawat, Somboon
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-05481-z
- URN
-
urn:nbn:de:101:1-2018080903005639289829
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bychkov, Andrey
- Vutrapongwatana, Usanee
- Tepmongkol, Supatporn
- Keelawat, Somboon
- SpringerLink (Online service)
Other Objects (12)
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
177Lutetium PSMA-radioligandtherapie bij prostaatkanker
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
177Lutetium PSMA-radioligandtherapie bij prostaatkanker
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
177Lutetium PSMA-radioligandtherapie bij prostaatkanker